Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Pharmaceutical Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 -August 02, 2023 at 07:13 am EDT | MarketScreener
Teva Pharmaceuticals (TEVA) Q2 2020 earnings: Reaffirms FY20 outlook | AlphaStreet
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceutical Industries Ltd. - Financials - Quarterly Results
Teva Pharmaceuticals on LinkedIn: #quarterlyresults #earnings #tevapharm
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva Pharmaceuticals reports higher quarterly profits, sales (copy)
Teva Reports Second Quarter 2023 Financial Results
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Teva Pharmaceutical Industries Limited 2022 Q4 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva Pharmaceutical Industries (NYSE:TEVA) Sees Large Volume Increase on Analyst Upgrade - MarketBeat
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Seasonal Chart | Equity Clock
Teva's Q3 triumph: 7% revenue surge propelled by Austedo and Ajovy
Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceutical Industries Ltd (ADR) Needs More Than Job Cuts
Teva shares climb as third-quarter sales top estimates - MarketWatch
TEVA Plunges on Q1 Results - TipRanks.com
Teva profit plummets, stock slides | Ctech
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Revenue Growth
Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs
Teva to cut up to 1,700 jobs in streamlining plan — report | The Times of Israel
Teva's Copaxone Successors Are Still Far From Success | Ctech
Teva Tops Q2 Earnings Forecast, Holds 2019 Guidance; CFO Departure Hits Shares - TheStreet
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
